Grifols SA ADR (GRFS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Grifols SA ADR

NASDAQ | GRFS

9.44

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$8.20B

Market Cap

18.27

P/E Ratio

0.51

EPS

$10.96

52 Week High

$6.09

52 Week Low

HEALTHCARE

Sector

GRFS Chart

Recent Chart

Price Action

GRFS Technicals

Tags:

GRFS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (EUR)
Gross Profit	$2.8B
Total Revenue	$7.2B
Cost Of Revenue	$4.4B
Costof Goods And Services Sold	$4.4B
Operating Income	$1.2B
Selling General And Administrative	$1.1B
Research And Development	$384M
Operating Expenses	$1.6B
Investment Income Net	-
Net Interest Income	-$701M
Interest Income	$44M
Interest Expense	$773M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$438M
Income Before Tax	$444M
Income Tax Expense	$231M
Interest And Debt Expense	-
Net Income From Continuing Operations	$213M
Comprehensive Income Net Of Tax	-
Ebit	$1B
Ebitda	$1.5B
Net Income	$157M

Revenue & Profitability

Earnings Performance

GRFS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (EUR)
Total Assets	$21B
Total Current Assets	$5.7B
Cash And Cash Equivalents At Carrying Value	$980M
Cash And Short Term Investments	$980M
Inventory	$3.6B
Current Net Receivables	$1.1B
Total Non Current Assets	$16B
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$2.9B
Intangible Assets Excluding Goodwill	$2.9B
Goodwill	$7.4B
Investments	-
Long Term Investments	$529M
Short Term Investments	$21M
Other Current Assets	$87M
Other Non Current Assets	-
Total Liabilities	$13B
Total Current Liabilities	$2.2B
Current Accounts Payable	$852M
Deferred Revenue	-
Current Debt	-
Short Term Debt	$640M
Total Non Current Liabilities	$11B
Capital Lease Obligations	$1.1B
Long Term Debt	$8.4B
Current Long Term Debt	$523M
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$10B
Other Current Liabilities	$508M
Other Non Current Liabilities	$45M
Total Shareholder Equity	$5.9B
Treasury Stock	-
Retained Earnings	$157M
Common Stock	$120M
Common Stock Shares Outstanding	$680M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (EUR)
Operating Cashflow	$902M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$438M
Capital Expenditures	$371M
Change In Receivables	-
Change In Inventory	$26M
Profit Loss	-
Cashflow From Investment	$887M
Cashflow From Financing	-$1.4B
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$962K
Dividend Payout Common Stock	$962K
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$0
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$444M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (EUR)
Gross Profit	$2.8B
Total Revenue	$7.2B
Cost Of Revenue	$4.4B
Costof Goods And Services Sold	$4.4B
Operating Income	$1.2B
Selling General And Administrative	$1.1B
Research And Development	$384M
Operating Expenses	$1.6B
Investment Income Net	-
Net Interest Income	-$701M
Interest Income	$44M
Interest Expense	$773M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$438M
Income Before Tax	$444M
Income Tax Expense	$231M
Interest And Debt Expense	-
Net Income From Continuing Operations	$213M
Comprehensive Income Net Of Tax	-
Ebit	$1B
Ebitda	$1.5B
Net Income	$157M

Dividends

Field	Value
Ex Dividend Date	2025-08-12
Declaration Date	2025-07-30
Record Date	2025-08-12
Payment Date	2025-08-20
Amount	0.175789

GRFS News

GRFS Profile

Grifols SA ADR Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

Grifols, SA (Ticker: GRFS) is a global leader in the pharmaceutical and biotechnology sectors, specializing in the research, production, and distribution of therapeutic products derived from human plasma. Headquartered in Barcelona, Spain, Grifols leverages its extensive network of plasma donation centers and innovative manufacturing capabilities to deliver vital therapies for patients with rare and chronic diseases. With a strong commitment to enhancing patient care and advancing healthcare solutions, Grifols continues to expand its product offerings and global reach, making it a key player in the healthcare industry.

Symbol	Price	Change %	Market Cap	Volume
VHAI	$0.00	+66.66%	$2.64M	883,708,745
YYAI	$0.17	-10.47%	$2.77M	383,798,684
BURU	$0.51	+7.74%	$62.82M	215,021,196
CGBS	$0.03	-39.47%	$18.16M	197,485,133
ELBM	$7.02	+325.45%	$29.87M	194,971,759

Symbol	Price	Change %	Market Cap	Volume
JNJ	$190.90	+0.09%	$460.19B	7,979,476
PG	$147.49	-1.46%	$352.69B	7,511,103
AZN	$84.51	-0.02%	$268.81B	5,979,944
NVO	$57.50	+1.00%	$259.42B	8,798,595
MRK	$85.70	-0.33%	$214.78B	6,553,942

Symbol	Price	Change %	Market Cap	Volume
ELBM	$7.02	+325.45%	$29.87M	194,971,759
GWH	$9.05	+117.54%	$66.65M	161,204,691
XCH	$1.68	+103.41%	$49.10M	36,930,538
AQMS	$9.91	+75.08%	$11.02M	18,942,482
VHAI	$0.00	+66.66%	$2.64M	883,708,745

Symbol	Price	Change %	Market Cap	Volume
SCPX	$0.00	-97.27%	$393.80K	21,515
ICCT	$0.00	-96.66%	$43.89K	3,168
TVRD	$6.69	-83.91%	$242.26M	6,266,780
SHOT	$0.39	-74.37%	$67.15M	13,958,900
CARM	$0.04	-70.30%	$6.43M	5,067,526

Quick Links

GRFS $0.00 (+0.00% ) Quote details